BioStock: Chordate Medical launches the trademark Ozilia

Chordate Medical introduces its new trademark, Ozilia, for the company’s preventive migraine treatment, formerly known as K.O.S. The new brand name will debut in the international arena during the International Headache Congress in Seoul, the largest global gathering of headache and migraine specialists. BioStock had the opportunity to discuss the company’s new trademark with CEO Anders Weilandt. 

Read the full article at biostock.se:

https://www.biostock.se/en/2023/09/chordate-medical-launches-the-trademark-ozilia/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se